WILLS EYE IS HIRING – CLICK HERE TO APPLY TODAY!

 

WILLS EYE RESEARCH NEWS

In the News

Clinical trial shows potential for treating glaucoma and diabetic retinopathy

In the News

Rapid Developments in Geographic Atrophy

Research News

Allen Ho, MD named to Nanoscope Therapeutics Visionary Advisory Committee

In the News

Optogenetics for retinal disease

Research News

Next-generation treatments for retinal disease

Research News

Effect on vision of GLP-1 drugs on older adults with diabetes

Research News

Clinical trial results for treatment of non-proliferative diabetic retinopathy

In the News

FLIO: an emerging imaging modality for ophthalmic and neurologic pathologies

In the News

Recap of Dr. Joel Schuman's Presentation at 2025 American Glaucoma Society Meeting

In the News

Insights on VERONA Clinical Trial of EYP-1901

In the News

Wills Eye at ARVO 2025

In the News

Second-Generation Anti-VEGFs in Age-Related Macular Degeneration

In the News

Electrical Stimulation Therapy: A Promising Approach to Vision Loss in Glaucoma and Other Optic Neuropathies

In the News

CVI a leading cause of visual impairment in children but often overlooked

In the News

Phase 2 DAVIO 2 Clinical Trial Results

In the News

Impact of Prior DME Treatment on Aflibercept 8 mg Outcomes

In the News

Video: Diabetic Macular Edema Study Results

Press Release

WILLS EYE GLAUCOMA LEADER RECEIVES $6.2 MILLION NIH AWARD FOR VISION RESEARCH

In the News

New Gene Therapy for Retinitis Pigmentosa Shows Promise

In the News

Wills to Present Study Results that Aid Detection of ATTR

Press Release

STUDY RESULTS ON ENDOPHTHALMITIS RATES AND TYPES OF TREATMENTS AFTER INTRAOCULAR PROCEDURES

In the News

Treating Wet AMD Patients Who Also Have Geographic Atrophy

In the News

Wills Study: Post-op Endophthalmitis Rates Down Fourfold Over 20-Year Period

In the News

Wills Residents Offer Strategies for AI in Healthcare